Iron Gate Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
989
+1
+0.1% +$1.02K 0.11% 37
2026
Q1
$909K Sell
988
-75
-7% -$76K 0.1% 42
2025
Q4
$1.14M Sell
1,063
-36
-3% -$34.4K 0.12% 36
2025
Q3
$838K Buy
1,099
+700
+175% +$521K 0.09% 47
2025
Q2
$311K Buy
399
+44
+12% +$34.2K 0.03% 66
2025
Q1
$294K Buy
+355
New +$295K 0.04% 70
2024
Q4
Sell
-252
Closed -$224K 93
2024
Q3
$224K Buy
252
+1
+0.4% +$899 0.03% 81
2024
Q2
$228K Buy
+251
New +$201K 0.04% 89

Other funds holding LLY

Iron Gate Global Advisors's LLY Position: Q2 2026 in Review

Iron Gate Global Advisors increased its Eli Lilly (LLY) stake by 0.1% in Q2 2026, buying an estimated $1.02K and bringing the position to 989 shares worth $1.19M. The position accounts for 0.11% of the portfolio, ranked #37.

Iron Gate Global Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Iron Gate Global Advisors held 989 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • Iron Gate Global Advisors bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.11% of Iron Gate Global Advisors's portfolio in Q2 2026, its #37 holding.
  • Iron Gate Global Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Iron Gate Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.